logo image

Glatiramer Acetate information from DrugsUpdate  

See Available Brands of Glatiramer Acetate in India

Glatiramer, a combined form of four amino acids is prescribed for the treatment of multiple sclerosis (MS) and prevention of relapses. The physiological action of amino acids modifies the immune system and prevents the immunological attacks on the myelin sheath of neurons.

Pharmacodynamics

No information available

Pharmacokinetics

No information available

Glatiramer Acetate Indications / Glatiramer Acetate Uses

No information available

Glatiramer Acetate Adverse Reactions / Glatiramer Acetate Side Effects

Glatiramer can cause injection-skin reactions, pounding heartbeats, chest pain, skin rashes, dizziness, troubled breathing, flushing, edema in the extremities, vaginal discharge, fever, chills, runny nose, weakness and back pain.

Precautions

Glatiramer is contraindicated in patients with allergy to mannitol or Glatiramer.

Special Precautions

No information available

Other Drug Interactions

No information available

Other Interactions

No information available

Dosage

Multiple Sclerosis (Adults):
To lower remission, frequency of relapses in relapsing-remission type MS, 20 mg, once daily, subcutaneous injection should be given.

Food(before/after)

No information available

List of Contraindications

Glatiramer Acetate and Pregnancy

USFDA pregnancy category B. Glatiramer acetate may not cause harm to an unborn foetus. Before Glatiramer acetate treatment, the patient should discuss with the physician, if they are planning for a pregnancy.

Glatiramer Acetate and Lactation

It is unclear whether the drug could pass through the breast milk to a breast feeding baby. Consult your physician before taking Glatiramer acetate if you are nursing mother.

Glatiramer Acetate and Children

No information available

Glatiramer Acetate and Geriatic

No specific information

Glatiramer Acetate and Other Contraindications

Information not available

Storage

Store at 20-25°C.

Lab interference

Store at 20-25°C.

© 2011-2018 DrugsUpdate.com. Disclaimer | Site Map

Feedback